Echinatin alleviates sepsis severity through modulation of the NF-κB and MEK/ERK signaling pathways

Biomed Pharmacother. 2024 Oct:179:117359. doi: 10.1016/j.biopha.2024.117359. Epub 2024 Sep 4.

Abstract

Sepsis, a frequently fatal condition, emerges from an exaggerated inflammatory response to infection, resulting in multi-organ dysfunction and alarmingly high mortality rates. Despite the urgent need for effective treatments, current therapeutic options remain limited to antibiotics, with no other efficacious alternatives available. Echinatin (Ecn), a potent bioactive compound extracted from the roots and rhizomes of licorice, has gained significant attention for its broad pharmacological properties, particularly its ability to combat oxidative stress. Recent research highlights the crucial role that oxidative stress plays in the onset and progression of sepsis further emphasizing the potential therapeutic value of Ecn in this context. In this study, we explored the protective effects of Ecn in a murine model of sepsis induced by cecal ligation and puncture (CLP). Ecn demonstrated a significant reduction in the levels of inflammatory cytokines and reactive oxygen species (ROS) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Network pharmacology analysis identified 41 targets and top 15 pathways involved in the Ecn-mediated signaling network, revealing that Ecn might exert its effects through key targets including the NF-κB and MAPK signaling pathways. Molecular docking studies suggested a strong affinity between Ecn and MEK, with kinetic simulations and binding energy calculations confirming a stable interaction. Mechanistically, Ecn treatment inhibited NF-κB and the MEK/ERK signaling pathway, as evidenced by decreased phosphorylation of IκBα and nuclear p65, along with reduced phosphorylation of MEK and ERK in both LPS-stimulated RAW 264.7 macrophages and septic mice. Furthermore, the administration of MEK signaling agonists reversed the anti-inflammatory effects of Ecn, indicating the involvement of this signaling pathway in Ecn's protective mechanism. Notably, our investigation revealed that Ecn did not affect bacterial proliferation either in vivo or in vitro, underscoring its specific immunomodulatory effects rather than direct antimicrobial activity. In summation, our findings underscored the potential of Ecn as an innovative therapeutic remedy for sepsis-induced injury, particularly through the regulation of the NF-κB and MEK/ERK signaling pathway. This exploration unveiled a promising therapeutic approach for treating sepsis, supplementing existing interventions and addressing their constraints.

Keywords: Cecal ligation and puncture; Inflammation; Lipopolysaccharide; Oxidative stress; P65.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Chalcones
  • Cytokines / metabolism
  • Disease Models, Animal
  • Lipopolysaccharides
  • MAP Kinase Signaling System* / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Molecular Docking Simulation
  • NF-kappa B* / metabolism
  • RAW 264.7 Cells
  • Reactive Oxygen Species / metabolism
  • Sepsis* / drug therapy
  • Sepsis* / metabolism
  • Signal Transduction / drug effects

Substances

  • NF-kappa B
  • echinatin
  • Reactive Oxygen Species
  • Lipopolysaccharides
  • Cytokines
  • Anti-Inflammatory Agents
  • Chalcones